BMC completed over 50 pediatric Bone Marrow Transplants
I n a landmark achievement, BMC completed over 50 pediatric Bone Marrow Transplants offering life- changing treatment to children from 16 countries. The 50th surgery was performed on Mona, who suffered from Thalassemia major, an autosomal recessive disorder resulting in severe anemia that demands lifelong blood transfusions. Over the years, the multi disciplinary team has treated a wide range of diseases, including Sickle Cell Disease, Primary Immunodeficiency (PID), Acu te Lymphoblastic Leukemia (ALL), Severe Combined Immunodeficiency (SCID), Griscelli Syndrome Type 2, Sideroblastic Anemia, Chronic Gran ulomatous Disease (CGD), Infant ALL, High-Risk Acute Myeloid Leukemia, Hemophagocytic Lymphohistiocytosis, Neuroblastoma, Hodgkin’s Disease, Pure Red Cell Aplasia, Hb Lepore Thalassemia, Severe Aplastic Anemia, Congenital Amegakaryocytic Throm bocytopenia (CAMT), Wiskott-Aldrich Syndrome(WAS), DOCK8 Deficiency, and Leukocyte Adhesion Deficiency (LAD).
Milestone In Pediatric Bone Marrow Transplants
Feat Focus Burjeel Holdings 9
Made with FlippingBook - professional solution for displaying marketing and sales documents online